TABLE 1.
Participant demographics with amorphous ribavirin-PRINT-CFI
| Demographics | Placebo (n = 12) | Amorphous ribavirin-PRINT-CFI |
Overall (n = 60) | |||||
|---|---|---|---|---|---|---|---|---|
| 7.5 mg (n = 6) | 15 mg (n = 6) | 30 mg (n = 6) | 30 mg (n = 12) | 60 mg (n = 6) | 60 mg (n = 12) | |||
| Mean age in yr (SD) | 35.3 (11.41) | 37.5 (13.46) | 32.5 (9.61) | 39.5 (12.28) | 39.1 (12.80) | 40.3 (12.29) | 34.7 (14.91) | 36.8 (12.31) |
| Sex, no. (%) | ||||||||
| Female | 0 | 1 (17) | 0 | 0 | 2 (17) | 2 (33) | 1 (8) | 6 (10) |
| Male | 12 (100) | 5 (83) | 6 (100) | 6 (100) | 10 (83) | 4 (67) | 11 (92) | 54 (90) |
| Mean BMI, kg/m2 (SD) | 24.33 (2.346) | 27.07 (0.836) | 25.08 (4.176) | 26.33 (2.902) | 25.91 (1.545) | 24.43 (2.657) | 24.62 (2.587) | 25.26 (2.537) |
| Mean wt, kg (SD) | 80.58 (10.411) | 82.87 (7.545) | 82.80 (15.558) | 85.47 (13.844) | 82.03 (9.721) | 72.78 (13.298) | 75.77 (8.649) | 80.07 (11.084) |
| Race, no. (%) | ||||||||
| Asian | 2 (17) | 0 | 1 (17) | 0 | 0 | 1 (17) | 4 (33) | 8 (13) |
| Black or African-American | 2 (17) | 2 (33) | 0 | 2 (33) | 2 (17) | 0 | 1 (8) | 9 (15) |
| White | 8 (67) | 3 (50) | 4 (67) | 4 (67) | 9 (75) | 5 (83) | 6 (50) | 39 (65) |
| Multiple | 0 | 1 (17) | 0 | 0 | 1 (8) | 0 | 1 (8) | 3 (5) |
| Not collected | 0 | 0 | 1 (17) | 0 | 0 | 0 | 0 | 1 (2) |